Lista publicaţiilor: Vanhoutte Frederic P. - 3

2019 - 1

Safety, pharmacokinetics, and antiviral activity of AT-527, a novel purine nucleotide prodrug, in hepatitis C virus-infected subjects with or without cirrhosis

Berliba Elina Tudor, Boguş Maxim , Vanhoutte Frederic P., Berghmans Pieter Jan , Good Steven Spencer , Moussa Adel , Pietropaolo Keith , Murphy Robert L. , Zhou Xiaojian , Sommadossi Jean Pierre

1 Timofei Moșneaga Republican Clinical Hospital, 2 SGS Life Sciences, Antwerp, 3 Atea Pharmaceuticals, Inc., Boston, 4 Northwestern University

Antimicrobial Agents and Chemotherapy

Nr. / 2019 / ISSN 0066-4804 / ISSNe 1098-6596

Disponibil online 4 December, 2019

-----------------------------------------------------------------------------------------------------------------------------------

2017 - 2

Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: Results from a randomised, dose-finding study (DARWIN 1)

Westhovens Rene, Taylor Peter Charles, Alten Rieke E.E., Pavlova Dace, Enriquez-Sosa F., Mazur Minodora Valentin, Greenwald Maria W., Van Der Aa Annegret, Vanhoutte Frederic P., Tasset Chantal, Harrison Pille

1 Catholic University of Leuven (KU Leuven), 2 Department of Rheumatology, University Hospitals Leuven, Leuven, 3 University of Oxford, 4 Schlosspark-Klinik Innere Medizin II, Berlin, 5 LTD mandM CENTRS, Adazi, 6 CLINSTILE, S.A. de C.V, Mexico City, 7 Institute of Cardiology, 8 Desert Medical Advances, Palm Desert, CA, 9 Galapagos NV, Mechelen

Annals of the Rheumatic Diseases

Nr. / 2017 / ISSN - / ISSNe 0003-4967

Disponibil online 20 February, 2018

-----------------------------------------------------------------------------------------------------------------------------------

Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Filgotinib, a Selective JAK-1 Inhibitor, After Short-Term Treatment of Rheumatoid Arthritis: Results of Two Randomized Phase IIa Trials

Vanhoutte Frederic P., Mazur Minodora Valentin, Voloshyn Oleksandr I., Stanislavchuk Mykola, Van Der Aa Annegret, Namour Florence, Galien Rene, Meuleners Luc, Van't Klooster Gerben

1 Galapagos NV, Mechelen, 2 ”Nicolae Testemițanu” State University of Medicine and Pharmacy, 3 Chernivtsi Regional Clinical Hospital, Chernivtsi, 4 Vinnytsia Regional Clinical Hospital, 5 Galápagos SASU, Romainville

Arthritis and Rheumatology

Nr. 10(69) / 2017 / ISSN 2326-5191

Disponibil online 7 February, 2018

-----------------------------------------------------------------------------------------------------------------------------------

10203040501005001000